Mirvetuximab soravtansine was the first ADC to show efficacy as a therapy for platinum-resistant ovarian cancer. Despite high ...

Elahere was found to improve survival in patients with FR-alpha–positive, platinum-resistant, high-grade serous epithelial ...

From model Bianca Balti’s ovarian cancer diagnosis to hockey pro’s testicular cancer diagnosis, here’s what’s happening in ...

September is recognized as Ovarian Cancer Awareness Month. But, do you know the signs and symptoms that could be impacting ...

Elahere, which won initial U.S. Food and Drug Administration approval in 2022 for platinum-resistant ovarian cancer, was the key asset in AbbVie's $10.1 billion acquisition of biotech ImmunoGen that ...

J&J's Red River Talc unit made its filing in the U.S. Bankruptcy Court for the Southern District of Texas. J&J faces lawsuits ...

Research has found 78% of women in the UK do not know the signs and symptoms of the five gynaecological cancers.

Johnson & Johnson said it received overwhelming support for a roughly $8 billion settlement of claims that its talc-based ...

A Johnson & Johnson subsidiary filed for bankruptcy for a third time on Friday as the healthcare giant seeks to advance an ...

The European Society for Medical Oncology’s annual meeting this week featured the hottest emergent areas of cancer ...

GILSON, Angela Thomas, 55, passed peacefully on September 15, 2024 surrounded by the love of her family after a two-year battle with ovarian cancer. Angie was born in Roanoke, Virginia, on March 26, ...

The healthcare-products company is taking another shot at resolving mass cancer lawsuits in chapter 11 after two failed ...